Gemcitabine Pancreatic Cancer. Uesaka k boku n fukutomi a et al. How gemcap is used.
More about gemcitabine hydrochloride. Since the introduction of gemcitabine pancreatic cancer may no longer be regarded a chemotherapy resistant tumor. Gemcitabine hydrochloride is also being studied in the treatment of other types of cancer.
On this page you will find information about.
Treatment with single agent gemcitabine achieved clinical benefit and symptoms improvement in 20 30 of patients. The chemotherapy drug gemcitabine has been a standard initial treatment for patients with metastatic pancreatic cancer for more than 15 years. Unresectable pancreatic cancer has a dismal prognosis with a median survival of 3 5 months in untreated disease. Treatment with single agent gemcitabine achieved clinical benefit and symptoms improvement in 20 30 of patients.
